A detailed history of Clearstead Trust, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clearstead Trust, LLC holds 3,708 shares of BMY stock, worth $208,760. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,708
Previous 3,695 0.35%
Holding current value
$208,760
Previous $153,000 24.84%
% of portfolio
0.05%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $515 - $672
13 Added 0.35%
3,708 $191,000
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $563 - $741
14 Added 0.38%
3,695 $153,000
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $623 - $707
13 Added 0.35%
3,681 $199,000
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $581 - $694
12 Added 0.33%
3,668 $188,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $49,785 - $55,667
860 Added 30.76%
3,656 $212,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $573 - $636
9 Added 0.32%
2,796 $178,000
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $525 - $596
8 Added 0.29%
2,787 $193,000
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $33,829 - $40,058
-494 Reduced 15.09%
2,779 $200,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $287 - $170,046
2,213 Added 208.77%
3,273 $232,000
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $65,624 - $71,465
1,060 New
1,060 $71,000
Q1 2021

Apr 30, 2021

SELL
$59.34 - $66.74 $62,900 - $70,744
-1,060 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $3,023 - $3,604
-67 Reduced 5.94%
1,060 $51,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $5,753 - $7,461
-118 Reduced 9.48%
1,127 $58,000
Q3 2018

Nov 15, 2018

SELL
$55.19 - $62.25 $22,683 - $25,584
-411 Reduced 24.82%
1,245 $77,000
Q2 2018

Aug 20, 2018

BUY
$50.53 - $62.98 $83,677 - $104,294
1,656 New
1,656 $92,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $119,061 - $137,063
-1,987 Closed
0 $0
Q2 2017

Aug 21, 2017

BUY
N/A
1,987
1,987 $111,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.